PE20070832A1 - Derivados de piridazinona como inhibidores de la tirosina quinasa - Google Patents

Derivados de piridazinona como inhibidores de la tirosina quinasa

Info

Publication number
PE20070832A1
PE20070832A1 PE2006001553A PE2006001553A PE20070832A1 PE 20070832 A1 PE20070832 A1 PE 20070832A1 PE 2006001553 A PE2006001553 A PE 2006001553A PE 2006001553 A PE2006001553 A PE 2006001553A PE 20070832 A1 PE20070832 A1 PE 20070832A1
Authority
PE
Peru
Prior art keywords
phenyl
atoms
inhibitors
kinase
naphthylus
Prior art date
Application number
PE2006001553A
Other languages
English (en)
Inventor
Dieter Dorsch
Oliver Schadt
Andree Blaukat
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PE20070832A1 publication Critical patent/PE20070832A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I DONDE R1 ES Ar1, Het; R2 ES Ar2, Het2; R3 ES H, A; A ES ALQUILO NO RAMIFICADO O RAMIFICADO QUE TIENE 1-10 ATOMOS DE C, EN DONE 1-7 ATOMOS DE H PUEDEN ESTAR REEMPLAZADOS POR F, Cl, ENTRE OTROS; Ar1 ES FENILO, NAFTILO, BIFENILO, ENTRE OTROS; Ar2 ES FENILO, NAFTILO, BIFENILO, ENTRE OTROS; Het Y Het2 SON CADA UNO HETEROCICLO SATURADO, INSATURADO O AROMATICO MONO-, BI- O TRICICLICO QUE TIENE 1-4 ATOMOS DE N, O, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 1-ETIL-3-{3-[3-(3-HIDROXIFENIL)-6-OXO-6H-PIRIDAZIN-1-ILMETIL]FENIL}UREA; 1-(3-{3-[3-(2-DIMETILAMINOETOXI)FENIL]-6-OXO-6H-PIRAZIDIN-1-ILMETIL}FENIL)-3-ETILUREA, CLORHIDRATO; ENTRE OTROS. REFERIDA TAMBIEN A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION. LOS COMPUESTOS DESCRITOS ACTUAN COMO INHIBIDORES DE LAS TIROSINA QUINASAS EN ESPECIAL LA MET-QUINASA, UTILES PAR EL TRATAMIENTO DE TUMORES
PE2006001553A 2005-12-05 2006-12-05 Derivados de piridazinona como inhibidores de la tirosina quinasa PE20070832A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005057924A DE102005057924A1 (de) 2005-12-05 2005-12-05 Pyridazinonderivate

Publications (1)

Publication Number Publication Date
PE20070832A1 true PE20070832A1 (es) 2007-08-27

Family

ID=37775213

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006001553A PE20070832A1 (es) 2005-12-05 2006-12-05 Derivados de piridazinona como inhibidores de la tirosina quinasa

Country Status (28)

Country Link
US (1) US8173653B2 (es)
EP (1) EP1960370B1 (es)
JP (1) JP5210172B2 (es)
KR (1) KR101367447B1 (es)
CN (1) CN101326167B (es)
AR (1) AR057214A1 (es)
AT (1) ATE527241T1 (es)
AU (1) AU2006322364B2 (es)
BR (1) BRPI0619407A2 (es)
CA (1) CA2632217C (es)
CY (1) CY1112206T1 (es)
DE (1) DE102005057924A1 (es)
DK (1) DK1960370T3 (es)
EA (1) EA014667B1 (es)
EC (1) ECSP088598A (es)
ES (1) ES2373117T3 (es)
HK (1) HK1127489A1 (es)
IL (1) IL191832A (es)
MY (1) MY153261A (es)
NZ (1) NZ569568A (es)
PE (1) PE20070832A1 (es)
PL (1) PL1960370T3 (es)
PT (1) PT1960370E (es)
SI (1) SI1960370T1 (es)
TW (1) TWI395741B (es)
UA (1) UA95934C2 (es)
WO (1) WO2007065518A1 (es)
ZA (1) ZA200805877B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS52626B (en) * 2006-07-25 2013-06-28 Cephalon Inc. PYRIDIZINONA DERIVATIVES
DE102006037478A1 (de) * 2006-08-10 2008-02-14 Merck Patent Gmbh 2-(Heterocyclylbenzyl)-pyridazinonderivate
CA2672601A1 (en) * 2006-12-14 2008-06-19 Astellas Pharma Inc. Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents
CN101668732A (zh) * 2007-04-02 2010-03-10 同一世界健康研究院 Cftr抑制剂化合物及其用途
DE102007025717A1 (de) * 2007-06-01 2008-12-11 Merck Patent Gmbh Arylether-pyridazinonderivate
DE102007025718A1 (de) * 2007-06-01 2008-12-04 Merck Patent Gmbh Pyridazinonderivate
DE102007026341A1 (de) 2007-06-06 2008-12-11 Merck Patent Gmbh Benzoxazolonderivate
DE102007032507A1 (de) * 2007-07-12 2009-04-02 Merck Patent Gmbh Pyridazinonderivate
DE102007038957A1 (de) * 2007-08-17 2009-02-19 Merck Patent Gmbh 6-Thioxo-pyridazinderivate
DE102007061963A1 (de) * 2007-12-21 2009-06-25 Merck Patent Gmbh Pyridazinonderivate
CN101537006B (zh) * 2008-03-18 2012-06-06 中国科学院上海药物研究所 哒嗪酮类化合物在制备抗肿瘤药物中的用途
DE102008019907A1 (de) 2008-04-21 2009-10-22 Merck Patent Gmbh Pyridazinonderivate
DE102008028905A1 (de) 2008-06-18 2009-12-24 Merck Patent Gmbh 3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazinderivate
DE102008037790A1 (de) 2008-08-14 2010-02-18 Merck Patent Gmbh Bicyclische Triazolderivate
US8586599B2 (en) * 2008-12-22 2013-11-19 Merck Patent Gmbh Polymorphic forms of 6-(1-methyl-1H-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-yl-ethoxy)-pyrimidin-2-yl]-benzyl}-2H-pyridazin-3-one dihydrogenphosphate and processes of manufacturing thereof
DE102008062826A1 (de) 2008-12-23 2010-07-01 Merck Patent Gmbh Pyridazinonderivate
DE102009003954A1 (de) * 2009-01-07 2010-07-08 Merck Patent Gmbh Pyridazinonderivate
DE102009004061A1 (de) 2009-01-08 2010-07-15 Merck Patent Gmbh Pyridazinonderivate
SG10201504735QA (en) 2009-01-08 2015-07-30 Merck Patent Gmbh Novel polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof
CN102731409A (zh) * 2011-04-08 2012-10-17 中国科学院上海药物研究所 一类哒嗪酮类化合物，其药物组合物、制备方法及用途
KR101842645B1 (ko) * 2012-04-12 2018-03-29 한국화학연구원 신규한 히드라진온이 치환된 피리미딘 유도체 및 그의 용도
CA2890273C (en) * 2012-11-02 2021-10-26 Merck Patent Gmbh A 6-oxo-1,6-dihydro-pyridazine derivative for the use for the treatment of hepatocellular carcinoma (hcc)
FI3640241T3 (fi) * 2013-10-18 2023-01-13 Bromodomeeni-inhibiittorit
CN103772352B (zh) * 2014-01-16 2017-01-18 四川百利药业有限责任公司 哒嗪酮类衍生物及其制备方法和用途
MX2017007374A (es) * 2014-12-11 2017-11-06 Merck Patent Gmbh Combinacion de un derivado de 6-oxo-1,6-dihidro-piridazina que tiene actividad anti-cancer con un derivado de quinazolina.
WO2018081381A1 (en) * 2016-10-26 2018-05-03 Proteostasis Therapeutics, Inc Pyridazine derivatives, compositions and methods for modulating cftr
CN107334767B (zh) * 2017-06-08 2019-03-05 中国医学科学院医药生物技术研究所 一种哒嗪酮类化合物在肿瘤治疗中的应用
EP3679027A1 (en) 2017-09-04 2020-07-15 C4 Therapeutics, Inc. Dihydrobenzimidazolones
EA202191082A1 (ru) 2018-11-06 2021-09-10 Эджвайз Терапьютикс, Инк. Соединения пиридазинонов и их применения
WO2020097258A1 (en) * 2018-11-06 2020-05-14 Edgewise Therapeutics, Inc. Pyridazinone compounds and uses thereof
CN113272291A (zh) 2018-11-06 2021-08-17 艾知怀斯治疗学公司 哒嗪酮化合物及其用途
EP3935050A4 (en) 2019-03-06 2023-01-04 C4 Therapeutics, Inc. HETEROCYCLIC COMPOUNDS FOR MEDICAL TREATMENT

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO79566A2 (ro) * 1980-05-28 1982-08-17 Institutul De Cercetari Chimico-Farmaceutice,Ro Substante din clasa 2-(3'-aril-piridazonil-1'5-metil-5-aril-(alchil)amino-tiadiazolului
RO79562A2 (ro) * 1980-05-29 1982-08-17 Institutul De Cercetari Chimico-Farmaceutice,Ro Substante din clasa 3-(3'-aril-piridazonil-1'5-metil-4-aril(alchil)-5-mercapto-1,2,4-triazolului si procedeu de obtinere a acestora
JPS5826802A (ja) * 1981-08-10 1983-02-17 Sankyo Co Ltd 農園芸用殺菌剤
DE3321012A1 (de) * 1983-06-10 1984-12-13 A. Nattermann & Cie GmbH, 5000 Köln Substituierte 4,5-dihydro-6-(thien-2-yl)-3(2h)-pyridazinone und 6-(thien-2-yl)-3(2h)-pyridazinone sowie verfahren zu ihrer herstellung
IE913310A1 (en) * 1990-09-21 1992-02-25 Rohm & Haas Dihydropyridazinones, pyridazinones and related compounds as¹fungicides
EP0478195B1 (en) 1990-09-21 1999-05-26 Rohm And Haas Company Dihydropyridazinones and pyridazinones as fungicides
AU691673B2 (en) * 1994-11-14 1998-05-21 Dow Agrosciences Llc Pyridazinones and their use as fungicides
CA2216512A1 (en) * 1996-10-11 1998-04-11 Rohm And Haas Company Dihydropyridazinones and pyridazinones their use as fungicides and insecticides
ES2260846T3 (es) * 1997-08-22 2006-11-01 Abbott Laboratories Inhibidores para la biosintesis de la prostaglandina h2 sintasa.
WO1999025697A1 (fr) * 1997-11-19 1999-05-27 Kowa Co., Ltd. Nouveaux derives de pyridazine et medicaments contenant ces composes comme principe actif
US7060822B1 (en) 1999-07-30 2006-06-13 Abbott Gmbh & Co. Kg 2-pyrazolin-5-ones
IL147757A0 (en) * 1999-07-30 2002-08-14 Abbott Gmbh & Co Kg 2-pyrazolin-5-ones
AUPR606401A0 (en) * 2001-07-02 2001-07-26 Fujisawa Pharmaceutical Co., Ltd. Pyrazolopyridine compound and pharmaceutical use thereof
EP1463509A1 (en) * 2001-10-31 2004-10-06 MERCK PATENT GmbH Type 4 phosphodiesterase inhibitors and uses thereof
WO2003059891A1 (en) * 2002-01-18 2003-07-24 Pharmacia Corporation Substituted pyridazinones as inhibitors of p38
WO2004022540A2 (en) * 2002-09-06 2004-03-18 Fujisawa Pharmaceutical Co., Ltd. Pyridazinone and pyridone derivatives as adenosine antagonists
NZ541064A (en) * 2003-03-07 2007-09-28 Kowa Co Benzofuran derivative
WO2004100960A2 (en) * 2003-04-25 2004-11-25 Gilead Sciences, Inc. Anti-inflammatory phosphonate compounds
CN101410120A (zh) 2003-04-25 2009-04-15 吉里德科学公司 抗炎的膦酸酯化合物
WO2006095666A1 (ja) * 2005-03-07 2006-09-14 Kyorin Pharmaceutical Co., Ltd. ピラゾロピリジン－４－イルピリダジノン誘導体とその付加塩及びそれらを有効成分とするｐｄｅ阻害剤

Also Published As

Publication number Publication date
IL191832A (en) 2013-09-30
ES2373117T3 (es) 2012-01-31
DE102005057924A1 (de) 2007-06-06
KR101367447B1 (ko) 2014-02-25
TWI395741B (zh) 2013-05-11
US8173653B2 (en) 2012-05-08
SI1960370T1 (sl) 2011-12-30
CA2632217C (en) 2014-07-08
ZA200805877B (en) 2009-07-29
HK1127489A1 (en) 2009-09-25
PT1960370E (pt) 2012-01-11
NZ569568A (en) 2011-05-27
JP2009518323A (ja) 2009-05-07
ATE527241T1 (de) 2011-10-15
CN101326167A (zh) 2008-12-17
US20080293719A1 (en) 2008-11-27
ECSP088598A (es) 2008-08-29
CA2632217A1 (en) 2007-06-14
AR057214A1 (es) 2007-11-21
PL1960370T3 (pl) 2012-01-31
WO2007065518A1 (de) 2007-06-14
JP5210172B2 (ja) 2013-06-12
AU2006322364A1 (en) 2007-06-14
CN101326167B (zh) 2011-03-09
UA95934C2 (ru) 2011-09-26
MY153261A (en) 2015-01-29
BRPI0619407A2 (pt) 2011-10-04
DK1960370T3 (da) 2012-01-02
EP1960370A1 (de) 2008-08-27
EA014667B1 (ru) 2010-12-30
EP1960370B1 (de) 2011-10-05
EA200801428A1 (ru) 2008-10-30
IL191832A0 (en) 2008-12-29
KR20080077664A (ko) 2008-08-25
CY1112206T1 (el) 2015-12-09
AU2006322364B2 (en) 2012-01-12
TW200804303A (en) 2008-01-16

Similar Documents

Publication Publication Date Title
PE20070832A1 (es) Derivados de piridazinona como inhibidores de la tirosina quinasa
AR113818A2 (es) Pirazolo-quinazolinas como inhibidores de proteína quinasa
PE20170247A1 (es) Derivados de pirrolidina-2,5-diona, composiciones farmaceuticas y metodos para usar como inhibidores ido1
PE20081362A1 (es) DERIVADOS MORFOLINO PIRIMIDINA COMO INHIBIDORES DE mTOR QUINASA Y PI3K
AR057109A1 (es) Benzimidazoles sustituidos y metodos para usarlos como inhibidores de las quinasas asociadas con la tumorigenesis
AR053569A1 (es) Derivados de pirazol
EA200701328A1 (ru) Замещенные триазольные производные в качестве антагонистов окситоцина
AR082109A1 (es) Derivados de bipiridilo
EA201070395A1 (ru) Ингибиторы polo-подобных киназ
ECSP045253A (es) Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa
PE20090048A1 (es) Derivados de glicina n-sustituidos: inhibidores de prolil hidroxilasa
PE20190656A1 (es) Compuestos de tiazolo-piridina sustituida como inhibidores de malt1
ECSP034865A (es) Resolución óptica de (1-benzilo-4-metilopiperidina-3-il)-metilamina y su uso para la preparación de derivados de pirrolo 2,3-pirimidina como inhibidores de proteina quinasas
ECSP077994A (es) Aminopirimidinas como moduladores de cinasa
EA201000093A1 (ru) Производные пиридазинона
PE20090511A1 (es) Imidazopiridinonas
PE20050462A1 (es) COMPUESTOS DE 5,7-DIAMINOPIRAZOLO[4,3-d]PIRIMIDINAS COMO INHIBIDORES DE LA FOSFODIESTERASA TIPO 5 (PDE-5)
ES2570127T3 (es) Compuestos y composiciones como inhibidores de la proteína quinasa
AR051755A1 (es) Compuestos biciclicos y triciclicos antagonistas del receptor cgrp
EA201070912A1 (ru) Производные оксима в качестве ингибиторов hsp90
ECSP078062A (es) Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen
AR049276A1 (es) Compuestos carboxamidos opiodes y composiciones farmaceuticas que los contienen
AR056860A1 (es) Derivados de triazol inhibidores de receptores de quinasa tgf-beta1, composiciones farmaceuticas que los contienen y usos para el tratamiento de tumores
ECSP099351A (es) Compuestos heterociclicos y su uso como inhibidores de la
PE20110213A1 (es) Derivados de indolinona como inhibidores de quinasa

Legal Events

Date Code Title Description
FG Grant, registration